Lovenox and Flunisolide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lovenox (enoxaparin sodium) and Flunisolide (flunisolide). Common drug interactions include cardiopulmonary failure among females and cardiac arrest among males.

The phase IV clinical study analyzes what interactions people have when they take Lovenox and Flunisolide. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Lovenox?

Lovenox has active ingredients of enoxaparin sodium. It is often used in deep venous thrombosis. eHealthMe is studying from 48,149 Lovenox users. Check the latest studies of Lovenox.

What is Flunisolide?

Flunisolide has active ingredients of flunisolide. It is often used in allergies. eHealthMe is studying from 2,318 Flunisolide users. Check the latest studies of Flunisolide.



On Jul, 14, 2026

29 people who take Lovenox and Flunisolide together, and have interactions are studied.

Lovenox and Flunisolide drug interactions.

What are the common drug interactions of Lovenox and Flunisolide, by gender? *:

female:

  1. Cardiopulmonary failure (cessation of normal circulation of the blood due to failure of the heart to contract)
  2. Dehydration (dryness resulting from the removal of water)
  3. Disseminated intravascular coagulation (systemic activation of blood coagulation)
  4. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  5. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  6. Haematoma (collection of blood outside the blood vessels)
  7. Haematuria (presence of blood in urine)
  8. Haemorrhage (bleeding)
  9. Injection site haemorrhage (bleeding from injection site)
  10. Multi-organ failure (multisystem organ failure)

male:

  1. Cardiac arrest
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Adult respiratory distress syndrome (type of lung (pulmonary) failure)
  4. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Bradycardia (abnormally slow heart action)
  7. Death
  8. Dyspnoea (difficult or laboured respiration)
  9. Emotional distress
  10. Fear

What are the common drug interactions of Lovenox and Flunisolide, by age (0-1 to 60+)? *:

0-1:

  1. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Renal failure (kidney dysfunction)
  2. Respiratory failure (inadequate gas exchange by the respiratory system)
  3. Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

  1. Adult respiratory distress syndrome (type of lung (pulmonary) failure)
  2. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  3. Bradycardia (abnormally slow heart action)
  4. Cardiac arrest
  5. Pneumonia
  6. White blood cell count decreased
  7. Neutropenia (an abnormally low number of neutrophils)
  8. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)

60+:

  1. Renal injury (kidney injury)
  2. Chronic kidney disease
  3. Abdominal pain
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Death
  7. Emotional distress
  8. Fear
  9. Injury
  10. Intra-abdominal haematoma (intra-abdominal localized swelling filled with blood)

What are the existing conditions these people have? *

  1. High Blood Pressure: 10 people, 34.48%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 24.14%
  3. Pain: 7 people, 24.14%
  4. Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 20.69%
  5. Muscle Spasms (muscle contraction): 6 people, 20.69%
  6. Joint Pain: 6 people, 20.69%
  7. Blood Oestrogen Decreased: 5 people, 17.24%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 4 people, 13.79%
  9. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 4 people, 13.79%
  10. Lung Infection: 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Lovenox and Flunisolide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lovenox and Flunisolide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lovenox:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Flunisolide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lovenox and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Flunisolide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on enoxaparin sodium and flunisolide (the active ingredients of Lovenox and Flunisolide, respectively), and Lovenox and Flunisolide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: